LCM
IRWD icon

Legato Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Legato Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Buy
+156,059
New +$640K 0.05% 520

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Legato Capital Management's IRWD Position: Q1 2026 in Review

Legato Capital Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 156,059 shares worth $548K. The stake represents 0.05% of the portfolio and ranks #520 among its holdings.

226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Legato Capital Management held 156,059 shares of Ironwood Pharmaceuticals worth $548K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Legato Capital Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.05% of Legato Capital Management's portfolio in Q1 2026, its #520 holding.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.